Par Drugs & Chemicals Share Price
₹199.40 +2.31 (1.17%)
22 Jan, 2025 12:28
Start SIP in PAR
Start SIPPerformance
- Low
- ₹194
- High
- ₹200
- 52 Week Low
- ₹181
- 52 Week High
- ₹348
- Open Price₹194
- Previous Close₹197
- Volume36,566
Investment Returns
- Over 1 Month -4.66%
- Over 3 Month -14.54%
- Over 6 Month -17.39%
- Over 1 Year -3.16%
Smart Investing Starts Here Start SIP with Par Drugs & Chemicals for Steady Growth!
Par Drugs & Chemicals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 13.4
- PEG Ratio
- 0.3
- Market Cap Cr
- 245
- P/B Ratio
- 2.9
- Average True Range
- 11.16
- EPS
- 14.85
- Dividend Yield
- 0
- MACD Signal
- -12.03
- RSI
- 42.97
- MFI
- 61.91
Par Drugs & Chemicals Financials
Par Drugs & Chemicals Technicals
EMA & SMA
Current Price
₹199.40
+
2.31
(1.17%)
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹202.26
- 50 Day
- ₹221.86
- 100 Day
- ₹233.27
- 200 Day
- ₹234.18
Resistance and Support
195.01
- R3 207.94
- R2 202.94
- R1 200.01
- S1 192.08
- S2 187.08
- S3 184.15
Par Drugs & Chemicals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-01-11 | Others | To consider other business matters issue in the ratio of 1:1 of Rs. 10/-. |
2024-10-22 | Quarterly Results | |
2024-08-17 | Others | To consider other business matters issue in the ratio of 1:1 of Rs. 10/-. |
2024-08-03 | Quarterly Results | |
2024-05-09 | Audited Results & Others |
Par Drugs & Chemicals F&O
About Par Drugs & Chemicals
- NSE Symbol
- PAR
- BSE Symbol
- Chairman & Managing Director
- Mr. Falgun Vallabhbhai Savani
- ISIN
- INE04LG01015
Similar Stocks to Par Drugs & Chemicals
Par Drugs & Chemicals FAQs
Par Drugs & Chemicals share price is ₹199 As on 22 January, 2025 | 12:14
The Market Cap of Par Drugs & Chemicals is ₹245.4 Cr As on 22 January, 2025 | 12:14
The P/E ratio of Par Drugs & Chemicals is 13.4 As on 22 January, 2025 | 12:14
The PB ratio of Par Drugs & Chemicals is 2.9 As on 22 January, 2025 | 12:14
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.